Shushant Jain

6.0k total citations · 2 hit papers
13 papers, 2.2k citations indexed

About

Shushant Jain is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shushant Jain has authored 13 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shushant Jain's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological diseases and metabolism (4 papers) and Alzheimer's disease research and treatments (3 papers). Shushant Jain is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological diseases and metabolism (4 papers) and Alzheimer's disease research and treatments (3 papers). Shushant Jain collaborates with scholars based in United States, Netherlands and United Kingdom. Shushant Jain's co-authors include Andrew Singleton, Alexandra Beilina, Mark Cookson, Patrick A. Lewis, Elisa Greggio, Andrew J. Lees, Alice Kaganovich, Kelly Jean Thomas Craig, Daniel G. Healy and Nicholas Wood and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Neuron.

In The Last Decade

Shushant Jain

12 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin

2006 591 citations Elisa Greggio, Shushant Jain et al. Neurobiology of Disease profile →
A common LRRK2 mutation in idiopathic Parkinson's disease

2005 575 citations William P. Gilks, Patrick M. Abou‐Sleiman et al. The Lancet profile →

Peers

Shushant Jain

NEURO

MB

NEURO

CMN

PHYSI

Julie P. Taylor United States

Coro Paisán‐Ruíz United States

Alice Kaganovich United States

Hiroyo Yoshino Japan

Justus C. Dächsel United States

Dora Yearout United States

Terina N. Martinez United States

Xian Lin China

Loukia Parisiadou United States

S. Lincoln United States

Julie P. Taylor United States

Shushant Jain

1.2k ×0.7

NEURO

604 ×0.7

MB

503 ×0.8

NEURO

425 ×0.7

CMN

377 ×0.7

PHYSI

Citations per year, relative to Shushant Jain Shushant Jain (= 1×) peers Julie P. Taylor

Countries citing papers authored by Shushant Jain

Since Specialization

Citations

This map shows the geographic impact of Shushant Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shushant Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shushant Jain more than expected).

Fields of papers citing papers by Shushant Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shushant Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shushant Jain. The network helps show where Shushant Jain may publish in the future.

Co-authorship network of co-authors of Shushant Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Shushant Jain. A scholar is included among the top collaborators of Shushant Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shushant Jain. Shushant Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Campbell, Matthew D., Martin Lipkin, Shushant Jain, et al.. (2024). Drug repurposing screen for the rare disease ataxia-telangiectasia. SLAS DISCOVERY. 30. 100200–100200.

2.

Jain, Shushant, Ronald E. van Kesteren, & Peter Heutink. (2012). High Content Screening in Neurodegenerative Diseases. Journal of Visualized Experiments. e3452–e3452. 5 indexed citations

3.

Jain, Shushant, David Sondervan, Patrizia Rizzu, et al.. (2011). The Complete Automation of Cell Culture: Improvements for High-Throughput and High-Content Screening. SLAS DISCOVERY. 16(8). 932–939. 10 indexed citations

4.

Jain, Shushant, Fiona M. F. Lun, Yama W. L. Zheng, et al.. (2011). SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells. PLoS ONE. 6(7). e21994–e21994. 12 indexed citations

5.

Jain, Shushant & Peter Heutink. (2010). From Single Genes to Gene Networks: High-Throughput-High-Content Screening for Neurological Disease. Neuron. 68(2). 207–217. 20 indexed citations

6.

Greggio, Elisa, Alice Kaganovich, Alexandra Beilina, et al.. (2008). The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation. Journal of Biological Chemistry. 283(24). 16906–16914. 244 indexed citations

7.

Lewis, Patrick A., et al.. (2007). The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochemical and Biophysical Research Communications. 357(3). 668–671. 214 indexed citations

8.

Johnson, Janel, Coro Paisán‐Ruíz, Grisel Lopez, et al.. (2007). Comprehensive Screening of a North American Parkinson’s Disease Cohort for <i>LRRK2</i> Mutation. Neurodegenerative Diseases. 4(5). 386–391. 21 indexed citations

9.

Greggio, Elisa, Shushant Jain, Ann E. Kingsbury, et al.. (2006). Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiology of Disease. 23(2). 329–341. 591 indexed citations breakdown →

10.

Nichols, William C., Nathan Pankratz, Dena Hernández, et al.. (2005). Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. The Lancet. 365(9457). 410–412. 347 indexed citations

11.

Gilks, William P., Patrick M. Abou‐Sleiman, Sonia Gandhi, et al.. (2005). A common LRRK2 mutation in idiopathic Parkinson's disease. The Lancet. 365(9457). 415–416. 575 indexed citations breakdown →

12.

Hernández, Dena, Coro Paisán‐Ruíz, Aideen McInerney‐Leo, et al.. (2005). Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Annals of Neurology. 57(3). 453–456. 84 indexed citations

13.

Jain, Shushant, Nicholas Wood, & Daniel G. Healy. (2005). Molecular genetic pathways in Parkinson's disease: a review. Clinical Science. 109(4). 355–364. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact